Denmark · Funded startup

Who invested in Liva Healthcare

One round we have observed, with the 0 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$9.1Mraised across 1 round since 2019, from 1 source

Latest round
Round, $9.1MMar 2019
Investors
0
See who backed them

The rounds

  1. Mar 2019
    Round$9.1M

    No investor was named in the report.

    Reported by Pharmiweb

Founders and team

From Liva Healthcare's own website: 10 on the team.

  • Hannah PearmanVice President, Operations
  • Martin PaarseCEO, Liva Healthcare
  • Harry MacMillanChief Partnerships Officer
  • Jane MasonChief People Officer
  • Kenneth JensenChief Product and Technology Officer
  • Nour HusseinChief Commercial Officer
  • Asger Anker ElnegaardData, Analytics and AI Director
  • Ellie HeathMedical Director
  • Kristo ScholtzLegal, Regulatory & Compliance Director
  • Lise Svendsen-TuneProduct Management Director

Also claim to have backed them

These 2 firms list Liva Healthcare as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

MIG FondsVC firmPer its own site
topconsult Raudner KGInvestment firmPer its own site

Quick answers about Liva Healthcare

How much has Liva Healthcare raised?

Liva Healthcare has raised $9.1M across 1 round since 2019.

When did Liva Healthcare last raise?

Liva Healthcare's most recent round was an Undisclosed round of $9.1M in Mar 2019.

What was Liva Healthcare's biggest round?

Its most recent round, $9.1M in Mar 2019, is also its largest on record.

What stage is Liva Healthcare at?

Liva Healthcare's latest named round is an Undisclosed round, in Mar 2019.

Where is Liva Healthcare based?

Liva Healthcare is based in Denmark.

Companies like Liva Healthcare

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.